One shared recovery pattern of kinase activity may extend life by completing tissue repair
The hypothesis proposes that one recovery pattern of extracellular signal-regulated kinase (ERK) activity in mature epithelium and skeletal muscle fibres could replace all four interventions. Any independent lifespan benefit surviving selective disruption of that pattern would reject the claim
Stage of verification
- Hypothesis published2026-10-05
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Enzyme
ERK
Kinases whose activity transmits signals within cells
Where this hypothesis actsMature epithelium and skeletal muscle fibers
Hypotheses on this target 3
Inhibition1
Activation1
Lower level
Higher level
Replacement
Protection from degradation
Cofactor removal
Synthesis suppression
Function preservation
What is proposed
Reproduce the restorative trajectory of ERK1/2 activity
HowUse a controllable signaling pathway activator to reproduce the ERK trajectory directly, replacing interventions B, L, C and E
Possible result
Possible completion of tissue repair, reduction of residual damage and extension of remaining lifespan
From the recordвоспроизведение восстановительной динамики внеклеточно регулируемых киназ ERK1/2 в зрелом эпителии и скелетных мышечных волокнах.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Different ways of helping the body recover might extend life through the same underlying process. The unexpected move is to propose that supporting gut cells, limiting susceptible bacteria, stimulating muscle activity and directing tissue repair can all be replaced by one shared pattern of signals inside cells. This is a hypothesis generated by the pipeline, not a measured result.
- Each of the four interventions is proposed to produce the same timed ERK1/2 activity pattern in mature lining cells and skeletal muscle fibers.
- Direct control of ERK1/2 is proposed to reproduce that pattern and replace all four interventions.
- The shared activity pattern is proposed to bring tissue repair to completion.
- Completed repair is proposed to reduce the damage left behind.
- Less remaining damage is proposed to increase remaining lifespan.
Four different buttons might start the same repair machine. If every useful effect comes from the machine following one operating sequence, starting that sequence directly could replace all four buttons.
Where the picture breaks: The interventions can also have distinct effects outside the proposed shared program. The supplied work does not establish that those effects are dispensable for longer life or that the same signal sequence is sufficient in both tissues.
- Master questionstep 01 of 04
Useful natural processes might be reproduced by substances, combinations or other interventions to extend life.
Rests on: The stated goal is to generate new hypotheses about interventions that reproduce beneficial bodily processes and explain why they might prolong life.
Stated in the chain - Goal pillarstep 02 of 04
The intended outcome is a defined set of new interventions that imitate bodily processes to extend life.
Rests on: The master question explicitly requests new candidates and explanations of their possible lifespan benefits.
Stated in the chain - Gap questionstep 03 of 04
The number of genuinely different life-extending interventions would be determined by replacing substances, removing components and changing the order of treatment phases to distinguish interchangeable actions from separately necessary functions.
Rests on: The preceding goal requests a defined set, but does not establish the targets or the rules for deciding when two interventions reproduce the same function.
AssumptionThe question takes established targets as given and assumes that replacement, removal and phase-order comparisons can distinguish functional independence. The preceding stages do not supply those targets or establish that criterion.
- Hypothesisstep 04 of 04
One reproducible activity pattern of extracellular signal-regulated kinases 1 and 2, abbreviated ERK1/2, proteins that relay signals inside cells, is proposed to account for all four interventions’ lifespan benefits. Reproducing that pattern in mature epithelium, the cells covering surfaces and lining organs, and skeletal muscle fibers, the elongated cells that contract to move the body, is predicted to complete repair, leave less damage and increase remaining life.
Rests on: The preceding question supplies the distinction between interchangeable interventions and independent functions. The hypothesis answers it by assigning all four interventions to one shared repair program.
AssumptionThe explicit assumption is that the entire lifespan contribution of all four interventions depends on the same ERK1/2 activity pattern, despite their different immediate effects, and that directly reproducing this pattern supplies every function needed for that benefit. Its status as an untested proposal is not itself a missing step.
What is carried, and what is not. Two screened sources provide adjacent evidence for the proposed connection between ERK1/2 and repair-related cell behavior: S2, an abstract from The Journal of Biological Chemistry (2003), reports that a blocking treatment prevented both reduced ERK chemical modification and inhibited movement in cultured human skin cells, while S4, in the International Journal of Molecular Sciences (2022), reports a temporary reduction in ERK1/2 chemical modification in human muscle precursor cells; neither establishes the required activity pattern or its effects in mature muscle fibers and intact tissues. These findings bear on one proposed connection, not the full sequence: no supplied source establishes that one shared pattern replaces all four interventions, completes repair, reduces remaining damage and extends life.S2S4
Where the reasoning is carried by something unstated · 2
- Gap question. The question takes established targets as given and assumes that replacement, removal and phase-order comparisons can distinguish functional independence. The preceding stages do not supply those targets or establish that criterion.
- Hypothesis. The explicit assumption is that the entire lifespan contribution of all four interventions depends on the same ERK1/2 activity pattern, despite their different immediate effects, and that directly reproducing this pattern supplies every function needed for that benefit. Its status as an untested proposal is not itself a missing step.
How a result here could mislead · 3
- Failure of direct ERK1/2 control to restore a lifespan benefit could be interpreted as failure of the hypothesis even if the intended pattern never reached both tissues. The supplied proposal gives no defined activity pattern or completed method for reproducing it across tissues in an old animal. What closes it: The target pattern and the criteria for successful reproduction must be specified before testing, and activity over time must be verified in both mature lining cells and skeletal muscle fibers. Increasing an average signal level does not establish reproduction of a timed pattern.
- Loss of every lifespan benefit after ERK1/2 disruption could be attributed to removal of the shared program when the disruption instead damages ordinary tissue function or prevents the interventions from producing their immediate effects. What closes it: Controls must establish how the same disruption affects tissue function and survival without the candidate interventions. The test must also verify the proposal’s requirement that immediate effects, including production of the relevant substances and muscle contractions, remain intact.
- Faster closure of a cultured wound could be read as completed repair caused by ERK1/2, although movement of cells can change through another route. S3, in Investigative Ophthalmology & Visual Science (2012), reports delayed wound closure through an ERK-independent route in cultured cells from the eye’s surface; it does not test the proposed shared pattern or lifespan.S3 What closes it: Cell movement or wound closure must be distinguished from restored tissue function and remaining damage. A claim about longer life additionally requires a lifespan measurement, and attributing repair to the proposed pattern requires verified control of that pattern.
What would make this wrong. The supplied prediction is broken if any one intervention retains an independent lifespan benefit after the proposed ERK1/2 pattern has been selectively disrupted in the named cells while that intervention’s immediate effects remain intact. The claim of sufficiency would also fail if verified reproduction of the specified pattern could not replace an omitted intervention’s lifespan contribution.
What it would change. If the prediction held, four apparently different candidates could count as one functional way of imitating a beneficial bodily process. Work on the master question would then have to distinguish new routes into that shared program from interventions that supply an additional life-extending function. Even a successful test would establish this only for the tested interventions, tissues and population; it would not show that one program replaces every possible longevity intervention or extends human life.
Sources read · 9
RSK2 Maintains Adult Estrogen Homeostasis by Inhibiting ERK1/2-Mediated Degradation of Estrogen Receptor Alpha. · Cell reports · 2020
“We discovered that ERK1/2-RSK2 activity oscillates during the estrous cycle.”
Does not settle: Источник не устанавливает восстановительную траекторию ERK1/2, завершение ремонта тканей, уменьшение остаточных повреждений или продление жизни. Он также не исследует скелетные мышечные волокна, воздействия B, L, C и E либо возможность заменить их управляемым активатором сигнального пути.
PP2A activation by beta2-adrenergic receptor agonists: novel regulatory mechanism of keratinocyte migration. · The Journal of biological chemistry · 2003
“Pretreating human keratinocytes with the PP2A inhibitor, okadaic acid, prevented the beta2-AR-induced inhibition of migration, either as isolated cells or as a confluent sheet of cells repairing an in vitro "wound" and also prevented the beta2-AR-induced reduction in ERK phosphorylation.”
Does not settle: The abstract links ERK phosphorylation to epithelial-cell migration in an in vitro wound model, but does not establish a reproducible recovery trajectory of ERK1/2, completion of tissue repair, effects in mature skeletal muscle fibers, reduction of residual damage, lifespan extension, or whether direct ERK activation can replace the proposed interventions.
EphA2/Ephrin-A1 signaling complexes restrict corneal epithelial cell migration. · Investigative ophthalmology & visual science · 2012
“Ephrin-A1-Fc treatment delayed wound healing independently of Mek-Erk1/2 signaling but was no longer capable of restricting migration after pharmacologic blockade of the PI3K-Akt pathway.”
Does not settle: Источник рассматривает заживление царапины в культуре эпителиальных клеток роговицы. Он не устанавливает роль заданной динамики ERK1/2 в зрелом эпителии других тканей или скелетных мышечных волокнах, не проверяет полноту восстановления ткани, остаточные повреждения, продолжительность жизни, общую траекторию для воздействий B, L, C и E или достаточность одного активатора пути.
Neuronal Agrin Promotes Proliferation of Primary Human Myoblasts in an Age-Dependent Manner. · International journal of molecular sciences · 2022
“Using primary human myoblasts, we determined that neuronal agrin induced transient dephosphorylation of ERK1/2, while c-Abl, STAT3, and focal adhesion kinase were unresponsive.”
Does not settle: The source does not establish a beneficial ERK1/2 recovery trajectory in mature epithelium or skeletal muscle fibers, completion of tissue repair, reduction of residual damage, lifespan extension, equivalence of interventions B, L, C, and E, or whether direct ERK activation can replace them.
Intermittent selective clamping improves rat liver regeneration by attenuating oxidative and endoplasmic reticulum stress. · Cell death & disease · 2014
“In contrast, lower p-JNK1/2 and higher p-p38 and p-ERK1/2 levels were observed following ISC procedure compared with PH and NCPH ( ).”
Does not settle: Источник показывает связь повышенного фосфорилирования ERK1/2 с улучшенным восстановлением печени после частичной гепатэктомии у крыс. Он не устанавливает требуемую динамику ERK1/2, причинную роль прямой активации, переносимость результата на зрелый эпителий и скелетные мышечные волокна, замену воздействий B, L, C и E одной программой или увеличение продолжительности жизни.
Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. · Current reviews in musculoskeletal medicine · 2025
“In endothelial cells, BPC-157 activates ERK1/2 signaling, enhancing proliferation, migration, and vascular tube formation through transcription factors like c-Fos, c-Jun, and Egr-1; ERK1/2 activation is required for its pro-healing effects both in vitro and in vivo, including in alkali-burn wound models”
Does not settle: The source does not establish a reproducible ERK1/2 trajectory in mature epithelium or skeletal muscle fibers, that directly reproducing such a trajectory can replace the other interventions or their distinct effects, that ERK1/2 alone completes tissue repair, or that it reduces residual damage and extends lifespan.
Versican Promotes Cardiomyocyte Proliferation and Cardiac Repair. · Circulation · 2024
“Mechanistically, versican activated integrin β1 and downstream signaling molecules, including ERK1/2 and Akt, thereby promoting cardiomyocyte proliferation and cardiac repair.”
Does not settle: Открытыми остаются специфическая траектория активности ERK1/2, её достаточность без других сигналов, переносимость результатов на зрелый эпителий и скелетные мышечные волокна, уменьшение остаточных повреждений и влияние на продолжительность жизни.
Umbilical cord blood-derived exosomes attenuate dopaminergic neuron damage of Parkinson's disease mouse model. · Journal of nanobiotechnology · 2024
“Importantly the expression of phosphorylated ERK (p-ERK) and phosphorylated MAPK p38 (p-p38) were significantly increased in the PD model group both in vivo and in vitro, while significantly decreased with intervention of UCB-Exos (Figs. E–F, 8E–F).”
Does not settle: The source does not test a defined recovery trajectory of ERK1/2, mature epithelium, skeletal muscle fibers, completion of tissue repair, residual damage, lifespan, or whether direct ERK control can replace interventions B, L, C, and E. It studies dopaminergic neuronal models in which reduced ERK hyperphosphorylation accompanies protection.
Neutrophil Survival Signaling During Francisella tularensis Infection. · Frontiers in cellular and infection microbiology · 2022
“We demonstrate that both ERK2 and p38α were activated in F. tularensis -infected neutrophils, but only p38α MAPK was required for delayed apoptosis and the rate of cell death in the absence of infection was unchanged.”
Does not settle: Источник не исследует зрелый эпителий, скелетные мышечные волокна, восстановительную динамику ERK1/2, завершение тканевого ремонта, остаточные повреждения или продолжительность жизни организма. Он также не проверяет, может ли управляемая активация ERK заменить воздействия B, L, C и E.
The gap this hypothesis explains
Nothing is known here: the question has not been asked of this system.
How many functionally distinct life-extending treatments remain after swapping substances, removing components, or reordering treatment stages?
Original wording · exactly as the pipeline generated it
Сколько функционально самостоятельных миметиков продления жизни образуют воздействия на установленные мишени, если замена веществ, исключение компонентов и перестановка фаз позволяют отделить взаимозаменяемые воздействия от воспроизведения разных необходимых функций?
What this question is asking
The question concerns how many different useful bodily functions a set of life-extending treatments reproduces, rather than how many substances it contains. It asks whether replacing substances, removing parts of a treatment, or changing the order of treatment stages distinguishes interchangeable treatments from treatments that reproduce different necessary functions. The proposed count must remain consistent when equivalent substances are substituted across repeated treatment cycles and survival is followed for the rest of life. This assumes that the treatments act on established biological targets and that these comparisons can identify separate functions; the supplied sources do not establish those assumptions for a specified set of treatments.
- Mimetic
- A substance or other intervention intended to reproduce an effect of a bodily process. In this question, mimetics would be counted by the useful functions they reproduce, rather than simply by their ingredients.
- Functionally independent
- Providing a distinguishable useful contribution that cannot simply be replaced by another contribution in the treatment set. The supplied material does not establish a precise rule for deciding when that condition is met.
- Necessary function
- A contribution required for a specified benefit under specified conditions. A treatment improving survival does not, by itself, establish which of its effects was necessary.
- Biological target
- A part of biological machinery, such as a protein, on which a treatment acts. Identifying a target does not by itself establish a survival benefit or a distinct necessary function.
- Interchangeability
- The ability to replace one treatment component with another while preserving the relevant function and outcome. Here, that equivalence is required to persist across repeated treatment and remaining-life follow-up.
- Component removal
- Leaving an ingredient or other element out of a combined treatment. The question asks whether the resulting change can distinguish redundant contributions from necessary ones.
- Treatment stage or phase
- One scheduled part of a treatment sequence. Reordering phases changes when components act relative to one another, even if the components themselves remain the same.
- Treatment cycle
- One complete repetition of a treatment schedule. The requested count must remain meaningful after multiple repetitions.
- Lifespan and remaining-life follow-up
- Lifespan is the length of an organism's life. Remaining-life follow-up means observing survival from the relevant starting point until death, rather than relying only on an earlier measurement.
- Additive effect
- A combined effect described as adding the contributions of the treatments on the study's measurement scale. S2 uses this description, but the supplied quotation does not give the scale, effect sizes, or a demonstration of separate necessary functions.
- Trametinib
- One of the drugs studied in S2. The supplied quotation reports lifespan extension in male and female mice but does not describe its biological target.
- Rapamycin
- The second drug in the combination reported by S2. The supplied quotation describes the combination as additive but does not specify rapamycin's separate effect size or mechanism.
- Protein assembly
- A group of proteins working together within a cell. S8 reports that the assemblies it discusses have distinct cellular functions, without establishing that these correspond to distinct life-extending mimetics.
- Genetic change
- An alteration to an organism's inherited biological instructions. S1 mentions such changes as one way aging is studied, without reporting how they resolve the functional-count question.
The interventions act on established targets, and substance substitution, component removal, and phase reordering can distinguish interchangeable interventions from reproduction of different necessary functions.
The assumption concerns substances or other treatments acting on identified parts of the body's machinery. It assumes that exchanging ingredients, leaving ingredients out, and changing when they are given can reveal whether treatments do the same useful job or different necessary jobs. If that distinction holds through repeated use and lifelong follow-up, it would provide a basis for counting treatments by function.
The supplied sources do not identify the complete treatment set or establish this counting rule. S2 reports an additive survival benefit from combining two drugs, but the supplied account does not establish interchangeability, necessary functions, or stability under repeated substitutions and schedule changes. S8 describes protein assemblies with distinct cellular functions, which does not establish distinct life-extending treatments. No supplied source establishes the premise; this limitation does not show that the premise is false.S2S8
The same question asked without the part nothing read establishes:
- For a specified set of life-extending treatments, what evidence distinguishes interchangeable ingredients from ingredients contributing different functions?
- Do changes in treatment ingredients or their order preserve the survival benefit across repeated treatment cycles and the remaining lifespan?
- One shared function If the treatments reproduce the same useful function and substitutions preserve the survival benefit, different ingredients would represent alternative ways of supplying that function. Counting each ingredient or formulation as a separate functional treatment would overcount.
- Several distinct necessary functions If different treatment components provide different necessary functions, replacing one component with something that supplies another function would leave a contribution missing. A count based only on interchangeable ingredients would then fail to capture the separate functions required for the benefit.
- The count depends on timing or repeated use If an ingredient's contribution changes with treatment order or repeated cycles, equivalence under one schedule would not establish equivalence under another. The result would be a count tied to particular treatment conditions, rather than the stable count requested.
A treatment's ingredients, the biological processes it changes, and its effect on survival are different things. If two ingredients reproduce the same useful function, counting ingredients separately could overstate the number of distinct treatments. If different ingredients provide different necessary functions, treating them as interchangeable could remove a contribution needed for the survival benefit. If their order matters, changing the schedule could change the benefit even when the ingredients stay the same. The question therefore turns on whether differences in composition or timing correspond to differences in function that persist over the remaining lifespan.
S-узлы уровней RL-1 и RL-2 описывают заменяемые компоненты и зависимость от режима, но не устанавливают число самостоятельных миметиков.
Число самостоятельных миметиков устойчиво к замене эквивалентных компонентов на протяжении повторных циклов и наблюдения оставшейся жизни.
Неизвестно, сколько разных причинных функций реализует набор воздействий и когда изменение состава или последовательности создаёт самостоятельный миметик.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Предлагаемый минимальный набор содержит один самостоятельный миметик: воспроизведение восстановительной динамики внеклеточно регулируемых киназ ERK1/2 в зрелом эпителии и скелетных мышечных волокнах. Воздействия B, L, C и E служат альтернативными входами в эту общую программу. Радикальное предположение состоит в том, что их вклад в продление жизни полностью определяется одной воспроизводимой траекторией ERK, хотя ближайшие метаболические, антимикробные и электрические эффекты различаются. Прямое воспроизведение этой траектории управляемым активатором сигнального пути должно заменить весь набор. Набор из одного кандидата достаточен, поскольку он воспроизводит все необходимые для выигрыша жизни функции; пустой набор сохраняет исходное состояние. Предполагаемая цепочка: восстановительная динамика ERK, завершение тканевого ремонта, уменьшение остаточных повреждений, увеличение оставшейся жизни.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
Избирательное нарушение восстановительной динамики ERK в названных клетках устраняет выигрыш жизни от каждого из четырёх воздействий при сохранении их ближайших эффектов, включая образование метаболитов и мышечные сокращения. Прямое воспроизведение траектории ERK восстанавливает тканевую функцию и выигрыш жизни после исключения любого из четырёх воздействий. Сохранение хотя бы одного самостоятельного выигрыша жизни при таком нарушении отвергает ответ «один» в пользу многокомпонентных ответов.
States a measurable outcome; comparing rivals needs more conditions. The text predicts loss and restoration of lifespan benefits under stated conditions, preservation of proximal effects, and an explicit rejection condition. These are measurable qualitative outcomes. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Динамику ERK и её управляемое воспроизведение можно исследовать в клеточных моделях. Проверка достаточности в нескольких тканях старого животного значительно сложнее и требует отдельных средств адресного управления. Продление жизни таким воздействием не доказано.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
Избирательное нарушение восстановительной динамики ERK в названных клетках устраняет выигрыш жизни от каждого из четырёх воздействий при сохранении их ближайших эффектов, включая образование метаболитов и мышечные сокращения. Прямое воспроизведение траектории ERK восстанавливает тканевую функцию и выигрыш жизни после исключения любого из четырёх воздействий. Сохранение хотя бы одного самостоятельного выигрыша жизни при таком нарушении отвергает ответ «один» в пользу многокомпонентных ответов.
- Rival 01 of 03What would separate them
Gut chemical defence and tissue recovery may extend life through two distinct functions predicts: После подтверждённого выпадения ответа на C воздействие E полностью восстанавливает заранее заданный профиль тканевого восстановления и соответствующий вклад в оставшуюся жизнь; обратная замена также успешна. Одновременное выпадение C и E устраняет этот вклад. Воздействия C или E не заменяют B+L. Исключение B либо L устраняет собственный выигрыш жизни микробного кандидата. Таким образом, две реализации C и E повышают надёжность одного миметика, сохраняя число самостоятельных кандидатов равным двум.
- What would separate them
Distinct signal decoders may separate muscle and epithelial longevity mimetics predicts: При сохранении суммарного воздействия изменение временного рисунка C избирательно устраняет мышечную адаптацию и её вклад в продолжительность жизни; E этот вклад не восстанавливает. Перестановка фаз E избирательно нарушает восстановление эпителия при сохранном ответе C. Возврат соответствующей последовательности восстанавливает только утраченную функцию. Одновременно B и L по отдельности сохраняют ближайшие эффекты, но выигрыш жизни даёт лишь их сочетание. Получается ровно три самостоятельных кандидата в ограниченном наборе.
- Rival 03 of 03What would separate them
Four distinct physiological mimetics may extend life through four independent functions predicts: B и L по отдельности увеличивают среднюю оставшуюся жизнь относительно контроля и сохраняют разные причинные зависимости. При замене чувствительных кишечных бактерий на функционально сопоставимые устойчивые варианты исчезает вклад L, тогда как вклад B сохраняется. При избирательном нарушении использования бутирата зрелыми колоноцитами исчезает вклад B, тогда как антимикробное действие и выигрыш от L сохраняются. Ни C, ни E не восстанавливают эти утраченные функции. Такая двойная диссоциация отвергает ответы с единым микробным кандидатом.
Why this is not the mainstream account
The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.
В клеточном исследовании электрическое поле вызывало разные последовательности активации и подавления ERK в зависимости от формы и времени воздействия. Это подтверждает значимость динамики сигнала, но не универсальность предложенного кода. [Исследование электрической модуляции ERK](https://www.nature.com/articles/s41598-024-53018-y).
Фармакология миметиков физической нагрузки и регенерации; пересмотра потребовал бы учебный раздел «Специфичность рецепторных путей и тканевых ответов». Центральное утверждение: разные физиологические прототипы имеют один достаточный исполнительный код для продления жизни.
Одна заданная траектория ERK полностью воспроизводит выигрыш жизни от всех четырёх воздействий, включая микробный метаболит с непосредственным антимикробным действием.
Строгий тест отсутствия этой идеи во всех обзорах выполнить нельзя. В проверенных источниках не обнаружено утверждения о полной взаимозаменяемости бутирата, изоаллолитохолевой кислоты, мышечной стимуляции и электрического восстановления эпителия через одну динамику ERK. Поэтому статус HERETICAL остаётся предварительным.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.